SCHEMBL3948078

SCHEMBL3948078

CCN(CC)C(=O)[C@H](C)N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 3/20 0.42
▸ LMNA P02545 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ MMP1 P03956 1/20 0.37
▸ MMP2 P08253 1/20 0.37
▸ MMP3 P08254 1/20 0.37
▸ MMP8 P22894 1/20 0.37
▸ HTT P42858 2/20 0.36
▸ HTR1A P08908 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ SLC15A1 P46059 1/20 0.32
▸ CA12 O43570 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ GABRP O00591 1/20 0.32
▸ GABRD O14764 1/20 0.32
▸ GABRA1 P14867 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5438409 1.00 DPP4 (0.42) DPP4LMNAALDH1A1MMP1MMP2
SCHEMBL5769336 0.85 DPP4 (0.35) DPP4LMNAALDH1A1HTTSMN1; SMN2
SCHEMBL5769339 0.85 DPP4 (0.35) DPP4LMNAALDH1A1HTTSMN1; SMN2
SCHEMBL15995187 0.84 DPP4 (0.37) DPP4LMNAALDH1A1MMP1MMP2
SCHEMBL19170142 0.81 DPP4 (0.39) DPP4LMNA
SCHEMBL9873959 0.80 CA12 (0.44) DPP4LMNAALDH1A1SLC15A1CA12
SCHEMBL6201950 0.80 CA12 (0.44) DPP4LMNAALDH1A1SLC15A1CA12
SCHEMBL1619585 0.80 DPP4 (0.47) DPP4LMNAALDH1A1MMP1MMP2
SCHEMBL1619583 0.80 DPP4 (0.47) DPP4LMNAALDH1A1MMP1MMP2
Hydrochloric Acid SCHEMBL19136969 0.80 DPP4 (0.38) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013628-A2 METHODS OF EVALUATING PEPTIDE MIXTURES Momenta Pharmaceuticals, Inc. (US) 2009-01-14 — — EP disclosed
WO-2007127977-A2 METHODS OF EVALUATING PEPTIDE MIXTURES MOMENTA PHARMACEUTICALS, INC. (US) 2007-11-08 — — WO disclosed
Send feedback